RetinalGenix Technologies (RTGN) Other financing activities (2024)

RetinalGenix Technologies (RTGN) posted Other financing activities of $60000.0 for Q2 2024, down 60.0% sequentially from $150000.0 in Q1 2024.

RetinalGenix Technologies (RTGN) Other financing activities (2024) Analysis & Trends

RetinalGenix Technologies has reported Other financing activities for 1 years, with the latest figure at $60000.0 in Q2 2024.

Quarterly Other financing activities changed N/A year-over-year to $60000.0 in Q2 2024, while the trailing twelve-month figure through Dec 2024 was $210000.0 (changed N/A YoY) and the FY2024 annual result came in at $210000.0, changed N/A from the prior year.
Other financing activities declined to $60000.0 in Q2 2024 per RTGN's latest filing, from $150000.0 in the prior quarter.
Over five years, Other financing activities peaked at $150000.0 in Q1 2024 and troughed at $60000.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.70 Bn	194.09 Bn	7.27 Bn
2	Stryker	127.31 Bn	123.83 Bn	4.50 Bn
3	Medtronic	118.93 Bn	109.71 Bn	6.41 Bn
4	Boston Scientific	73.35 Bn	72.82 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn
6	Dexcom	34.35 Bn	32.40 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn
10	RetinalGenix Technologies	75.02 Mn	75.02 Mn	-

Download Data